ARCHIVES

US Oncology Renegotiates Agreements To Operate Under Net Earnings Model.

This article is from The Cancer Letter archive.

Vol. 27 No. 13 | March 30, 2001

Download PDF Visit The Full Archive

Related Articles

NRC Group Splits Over chemical Dose Testing For Carcinogenicity

March 12, 1993

Broder; Cancer Act’s Special Authorities Don’t Give Director Immunity For NIH, HHS

September 27, 1991

Studies Shed Light On Racial Disparities Between Blacks, Whites With Breast Cancer

July 31, 2009

Nutrition RFP Canceled, Job Added To Existing Contract

April 4, 1975

Dendreon’s Provenge Approved For Prostate Cancer Treatment

April 30, 2010

Prime Contract Subcontract Opportunities

January 24, 1975